5Giddings G,Allison G, Brook s D. Transgenic plants as factories for biopharmaceuticals [ J]. Nat Biotechnol, 2000, 18 ( 11 ) : 1151 - 1155.
6M a J K. Genes, greens and vaccines [J]. Nat Biotechnol,2000,18 (11) :1141 -1142.
7Macchia G, Massone A, Burroni D,et al. The Hsp60 protein of Helicobacter pylori: structure and immune response in patients with gastroduodenal diseases [ J ]. Mol Microbiol, 1993 (9) :645 - 652.
8Marchetti M,Arico B, Burroni D,et 1. Helicobacter trylori infection in a mouse model that mimics human diseases [ J ]. Science, 1995,267 : 1655 - 1658.
9Yamaguehi H, Osaki T, Taguehi H. Growth inhibition of Helicobacter Fylori by monoelonal antibody to heat-shock protein 60 [ J ]. Mierobiol Immunol, 1997,41:909 - 916.
10Censini S,Lange C,Xiang Z, ct al. Cag, a pathogenicity island of Helicobacter p)lori, encodes type I specific and disease-associated virulence facters[ J]. Proc Natl Acad Sci USA, 1996,93:14648 - 14653.
